ContractMorgan Credit Agreement • June 22nd, 2010 • Tredegar Corp • Rolling drawing & extruding of nonferrous metals • New York
Page ARTICLE I Definitions 1 SECTION 1.01. Defined Terms 1 SECTION 1.02. Classification of Loans and Borrowings 19 SECTION 1.03. Terms Generally 19 SECTION 1.04. Accounting Terms; GAAP 19 SECTION 1.05. Status of Obligations 20 ARTICLE II The Credits 20 SECTION 2.01. Commitments 20 SECTION 2.02. Loans and Borrowings 20 SECTION 2.03. Requests for Revolving Borrowings 21 SECTION 2.04. Determination of Dollar Amounts 21 SECTION 2.05. Swingline Loans 22 SECTION 2.06. Letters of Credit 23 SECTION 2.07. Funding of Borrowings 27 SECTION 2.08. Interest Elections 27 SECTION 2.09. Termination and Reduction of Commitments 29 SECTION 2.10. Repayment of Loans; Evidence of Debt 29 SECTION 2.11. Prepayment of Loans 30 SECTION 2.12. Fees 31 SECTION 2.13. Interest 31 SECTION 2.14. Alternate Rate of Interest 32 SECTION 2.15. Increased Costs 33 SECTION 2.16. Break Funding Payments 34 SECTION 2.17. Taxes 34 SECTION 2.18. Payments Generally; Pro Rata Treatment; Sharing of Set-offs 36 SECTION 2.19. Mitigatio
ASSET BASED LENDINGMorgan Credit Agreement • August 4th, 2016 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
CREDIT AGREEMENT dated as of June 1, 2016 (as it may be amended or modified from time to time, this "Agreement") among ACORDA THERAPEUTICS, INC., a Delaware corporation (the "Company"), CIVITAS THERAPEUTICS, INC., a Delaware corporation ("Civitas"), and NEURONEX, INC., a Delaware corporation ("Neuronex", and together with the Company, Civitas, and Neuronex, each, individually, a "Borrower" and collectively, the "Borrowers"), the other Loan Parties party hereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
